Macrophages play a central role in maintenance of the steady state, in body defense against infectious or neoplastic challenge, and in control of inflammation largely through the secretion of soluble factors or cytokines (1, 2) . Paradoxically, these scavenger cells also represent a major cellular reservoir for many microbial pathogens, including HIV (3) . The HIV-infected macrophage continuously produces progeny virus through both subclinical infection and overt disease, often in the face of a vigorous, virus-induced, host immune response. There is strong evidence that resident tissue macrophages of the central nervous system (4-6), lung (7), lymph nodes (8) , and blood monorytes (9-11) each harbor HIV, and support its replication . How HIV infects macrophages and contributes to clinical disease is mediated in part by the complex interactions between the mononuclear phago-1433 cyte of each tissue and the other cell types which result in the production of injurious secretory products or cytokines . 114, TNF-a, and 11, 6 have each been implicated in the pathogenesis of disease symptoms during HIV infection (12) . HIV can also directly induce cell dysfunction and alter host immune responses to affect the virus-target cell interaction and disease pathogenesis (13) (14) (15) .
The mechanisms for persistence by HIV in mononuclear phagocytes, cells whose prime function evoked for destruction of foreign pathogens, are poorly understood. One possibility involves the dysregulation of normal cell differentiation and microbicidal function induced by virus. Many of these macrophage functions are mediated by autocrine and paracrine cytokines . One such cytokine, IFN-a, is particularly important as it is involved in both cell differentiation and in defense against viral and nonviral infectious pathogens. Indeed, IFN-a can significantly suppress or prevent the replication of many animal lentiviruses including HIV (16) . In a recent placebo-controlled clinical trial, IFN-a showed signficant antiviral activity in HIVinfected patients treated early in the course of disease (17) . The replication of visnamaedi virus in sheep macrophages is also restricted in vivo by IFN (18) . Restricted lentivirus replication induced by IFN in macrophages and/or CD4' lymphocytes is a consequence of specific and selective transcriptional blocks in expression of viral genes and also interference with the mechanisms for viral assembly and maturation during the virus life cycle (19) (20) (21) . Characterization of IFN regulation in the HIV infected macrophages may permit insight into the virus-host cell adaptive mechanisms that result in HIV survival and persistent replication in cells of macrophage lineage.
Materials and Methods
Isolation and Culture of Monocyte Target Cells. Monocytes were recovered from PBMC of HIV and hepatitis B-seronegative donors after leukapheresis and purified by countercurrent centrifugal elutriation of mononuclear leukocyte-rich fractions of blood cells. Cell suspensions were >98% monocytes by criteria of cell morphology on Wright-stained cytosmears, by granular peroxidase, and by nonspecific esterase . Monocytes were cultured as adherent cell monolayers (7 .5 x 105 cells/24 mm plastic culture well) in 0.5 ml DMEM (formula 78-176AJ ; Gibco Laboratories, Grand Island, NY) with 10% heat-inactivated A+ human serum, 50 wg/ml gentamicin, and 1,000 U/ml highly purified (<0.01 ng/ml endotoxin) recombinant human macrophage CSF (M-CSF)' (FAP-809, a generous gift from the Cetus Corp., Emeryville, CA) (22) . All culture reagents were screened and found negative for endotoxin contamination .
HIV Infection of Monocyte Targets. M-CSF-treated monorytes were exposed at a multiplicity of infection (MOI) of 0.01 infectious virus/target cell to the ADA HIV strain originally isolated and passaged in monocytes (22) . HTLVIIIB/H9 (contributed by Dr. R. Gallo) was obtained from the AIDS Research and Reference Reagent Program, AIDS Progam, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD). All viral stocks were tested and found free of mycoplasma contamination (Gen-probe II ; Gen-probe Inc., San Diego, CA). M-CSF-treated monorytes were cultured as adherent monolayers 7-10 d before use as target cells. All cultures were refed with 50% fresh medium every 2-3 d. Levels of p24 antigen (Ag) in culture fluids were determined by ELISA (E . I . Dupont de Nemours & Co ., Billerica, MA). For reverse transcriptase (RT) activity, replicate samples of culture fluids were added to a reaction mixture of 0.05% NP-40 (Sigma Chemical Co ., St . Louis, MO), 10,ug/ml poly(A), 0.25 U/ml oligo(dT) (Pharmacia Fine Chemicals, Piscataway, NJ), 5 mM dithiothreitol (Pharmacia), 150 mM KCI, 15 MM MgC12, and [3H]dTTP (2 Ci/mmol; Amersham Corp ., Arlington Heights, IL) in pH 7.9 Tris-HCI buffer for 24 h at 37°C . Radiolabeled nucleotides were precipitated with cold 10% TCA and washed with 5% TCA and 95% ethanol in an automatic cell harvester (Skatron Inc., Sterling, VA) on glass filter discs. Ra-dioactivity was estimated by liquid scintillation spectroscopy (23) . HTLVIIIB served as positive control for both p24 Ag and RT activity.
Growth ofMacrophage Variant HIV in Macrophage Targets . Macrophage variant HIV initially isolated onto M-CSF-treated monorytes by cocultivation with PBMC from HIVseropositive patients was serially passaged on monocyte target cells. Such macrophage variant HIV infects both monocyte and T cell targets (24) . For the HIV isolate ADA, infection of monocyte targets at an MOI of 0.01 infectious virus/target cell induced: (a) typical cytopathic effects (multinucleated giant cells and lysis), (b) p24 Ag levels initially detected in culture fluids at 3-5 d with maximum levels >50 ng/ml, (c) levels of RT activity in culture fluids 360 x 106 cpm/ml, (d) proviral HIV DNA detected 12 h after infection by PCR amplification with peak levels at 10 d, and (e) infectious titers for macrophages of 1 x 10 4 TCID5o /ml.
Detection of HIV-specific c DNA by PCR Amplification and Southern Blot Hybridization . Cell lysates of HIV-infected monorytes were extracted twice with phenol and chloroform/isoamyl alcohol and the DNA was precipitated with ethanol. PCR amplification of HIV specific DNA with nucleotide primers from the LTR and gag genes and 2.5 U/ml Taq polymerase (Cetus Corp.) was performed with an automatic cycler (Perkin Elmer-Cetus, Emeryville, CA). The products of 40 cycles (5 min at 90°C initial denaturation, then 2.5 min at 94°C, 3 min at 55°C, and 2 min at 72°C) were analyzed by Southern blot hybridization after agarose gel electrophoresis with a radiolabeled DNA probe specific for a gag sequence internal to the primer pairs (25 and (26) . Dot Blot Analysis of mRNA . Total RNA was extracted from cell lysates with acidic guanidinium isothiocyanate/phenol/chloroform and analyzed by Northern blot hybridization on nylon membranes (Nytran; Schleicher & Schuell, Keene, NH) with a radiolabeled 2,5' oligoadenylate synthetase probe (27) .
Induction of Cytokines in HIVinfected Cells. At various times after HIV infection, monocytes were treated with 100 ug/ml poly(I). poly(C) (Sigma Chemical Co .) for 4 h. Cultures were washed free of poly(I).poly(C) and refed with fresh medium . Newcastle disease virus was prepared in hen's eggs (20) and used at a MOI of 1 infectious virus/target cell to infect HIV-infected and control monocytes. HSV type-1 was prepared from stock in Vero cells and provided as a generous gift from Dr. D. Gangemi, Columbia, SC . HSV was used at a MOI of 1 infectious virus/target cell to infect monocyte cultures .
Quantitation of Cytokine Activity. Culture fluids from control and HIV-infected monocytes were analyzed by ELISA for the human cytokines TNF-a, IIT1J3, 11,6, and IIL4 (Quantikine Immunoassay; Research and Diagnostics Systems, Minneapolis, MI). IFN activity in culture fluids was assayed by inhibition of cytopathic effects in-duced by murine encephalomyocarditis virus in FS-4 human foreskin fibroblasts (28) .
Coupled Reverse Transcription/PCR Detection ofCytokine and HIV specific RNA. Levels of cytokine or viral RNA were estimated after reverse transcription with antisense primers and PCR amplification of the cDNAs. The mRNA for the cellular enzyme, glyceraldehyde 3-phosphate dehydrogenase (GAPDH), served as an internal control to allow analysis and comparison of RNA species between different samples. Briefly, 2.0 hg total cellular RNA in 0.025 ml was mixed with 0.3 wg of the antisense primers for GAPDH (29) , TNF-a (30), ILI# (31), IIJ6 (32), IFN-a (33), IFN-w (34), IFN-0 (35), and HIV LTR/gag (25) . Table 1 lists the primer sequences used. The mixture was heated at 70°C for 5 min, cooled 1435 Gendelman et al .
on ice, and treated with 500 U Moloney murine leukemia virus RT (Bethesda Research Laboratories, Bethesda, MD) and 0.5 mM each of all four deoxynucleotide triphosphates. Reverse transcription reactions were at 37°C for 15 min then stopped by heating at 95°C for 10 min. For PCR amplification of the cDNA products, reaction mixtures were divided into equal aliquots and mixed with 0.5 I~g sense and antisense primers, 0.5 mM deoxynucleotide triphosphates, and 2 U Amplitaq (Cetus Corp.) . The products of 25 cycles (1 .5 min at 94°C, 1.5 min at 50°C, and 2.0 min at 72°C) were analyzed by Southern blot hybridization (36) . The oligonucleotides were synthesized on a DNA synthesizer (Applied Biosystems, Inc., Foster City, CA) and checked for purity by polynucleotide kinase labeling and sequence gel analysis. Oligonu- cleotides were typically 95% pure. Hybridization analyses of HIV LTR/gag amplified cDNAs were also performed with random primer-labeled 370-bp HIV DNA internal to the primer pairs .
Results
Cytokine Activities in Culture Fluids of HIVinfected Monocytes. No IFN activity (inhibition of murine encephalomyocarditis virus-induced cytopathic effects in human foreskin fibroblasts) was detected in culture fluids of uninfected or HIVinfected monorytes with any of 15 different HIV isolates at any time through 3 wk of culture. Similarly, levels of TNF-a, lL1(3, or IL-6 in culture fluids of uninfected and HIV-infected monorytes as quantified by ELISA were 4_1 pg/ml for all times examined through 2 wk. Fluids from monocyte cultures were examined for cytokine activities every 2 d. fluids from uninfected control monorytes treated with poly(I)-poly(C) or NDV contained high levels of IFN activity ( Fig. 1) . Analysis of the time course for production of IFN activity at 3 h intervals revealed maximum levels (>1,000 U/ml) 20-24 h after treatment . Neutralization studies with class-specific anti-IFN antibodies showed that >98% of antiviral activity was IFN-a . By 43 h, all IFN activity in these culture fluids returned to baseline levels. In striking contrast, culture fluids from HIVinfected monorytes treated with these identical agents had little IFN activity at any time through 54 h. HIV-infected monocytes were treated with poly(I)-poly(C) or NDV 2 wk after virus inoculation : -45-60% of monorytes in these cultures were positive for HIV mRNA by in situ hybridization ; levels of p24 Ag in culture fluids were >50 ng/ml. In more than 10 replicate experiments with 3 different HIV isolates (strains ADA, 24, and 36), little IFN activity (S 10 U/ml) was detected in culture fluids of HIVinfected monorytes treated with 10-500 itg/ml poly(I)-poly(C), NDV, or HSV type-112-18 days after HIV inoculation .
The preceding data documents a profound defect in the production ofIFN-ci by monorytes infected with HIV after treatment with any of several different IFN inducers. Further experiments explored the relationship between time after HIV infection and the onset of this functional defect . Monocytes cultured 7 d as adherent monolayers were exposed to the HIV isolate ADA at an MOI of0.01 infectious virus/target cell. At 1, 3, 5, 7, and 14 d after virus infection, HIVinfected monorytes were treated with 100 hg/ml poly(I)-poly(C) for 4 h. ON activity in culture fluids of HIVinfected and matched uninfected control monorytes was measured 24 h after poly(l)-poly(C) treatment . IFN activity in culture fluids of uninfected poly(I) .poly(C)-treated monorytes was 1250 IU/ml . HIV infection had no effect on poly(I)-poly(C)-induced IFN levels in monoryte culture 1 d after virus infection. By 3 d after HIV infection, the levels of IFN activity in these monoryte cultures were reduced by 50%. The reduction in poly(I)-poly(C)-induced ON activity in culture fluids of HIVinfected monocytes increased with time with infection: 80% by day 5, 90% by day 7, and >,98% by day 14.
Induction of Cytokine Gene Expression in HIVinfected Monocytes by poly(I}poly(C}. To further quantitate the extent and specificity of the HIV-induced defect in IFN production by poly(I)-poly(C)-treated, HIVinfected monocyte cultures, we examined ON-u-specific mRNA using coupled reverse transcription/PCR analysis . Levels of mRNA for the constitutive cellular enzyme GAPDH were also examined as a reference transcript to confirm the presence of cellular RNA and the efficiency of PCR amplification for all samples (Fig. 2) . GAPDH mRNA amplification products were present at equivalent levels with the cell lysates of all cultures examined. No IFN-u mRNA amplification products were detected with cell lysates from uninfected or HIV-infected monocyte cultures not treated with poly(I)-poly(C) (lanes 1 and 2) . The predicted 274-bp amplification product ofIFN-a mRNA was evident with cell lysates of uninfected monocyte cultures 8, 12, and 24 h aftei poly(l) -poly(C) treatment (lanes 3, 5, and 7) . In contrast, this IFN-cx mRNA amplification product The specificity of this HIV-associated transcriptional block in the expression of IFN-a genes was explored by quantitation ofmRNA for several other cytokines induced in monocytes by poly(I)-poly(C) (Fig . 3) . Coupled reverse transcription/PCR analysis of mRNA for IL1O, IL-6, and TNF-ot in cell lysates of uninfected and HIV-infected monocyte cultures showed no or little (111(3 in HIV-infected monocytes) cytokine mRNA amplification products. These results are consistent with the absence ofthese cytokines as detected by ELISA in the monocyte culture fluids. After poly(I)-poly(C) treatment, however, high and indistinguishable levels of amplification products for mRNA of IL1# (179-bp product), 11,6 (159-bp product), and TNF-a (237-bp product) were identified with cell lysates from both uninfected and HIV infected monocyte cultures. These relatively high levels of mRNA products were associated with similarly high concentrations of these same cytokines in monocyte culture fluids as detected by ELISA (Table 2) . Thus, strong HIV-associated 1437 Gendelman et al . Cytokine levels with time after treatment:
Monocytes cultured 7 d as adherent monolayers were exposed to HIV at a MOI of 0.01 infectious virus/target cell . 2 wk after infection, 100 Wg/ml poly(I)-poly(C) was added to HIV-infected and uninfected control cultures for 4 h. All cultures were washed free of poly(I)-poly(C) and refed with fresh medium . Cytokine levels in culture fluids were determined by ELISA. (lanes 2-5) . This reduction in viral mRNA was coincident with an equivalent reduction in p24 Ag and RT activity levels in the same cultures . In contrast, levels of HIV mRNA in infected monocyte cultures not treated with poly(I).poly(C) increased over the same time interval (lane 6) .
poly(I)
It is possible that this antiviral activity was mediated by the low levels of IFN-0 and IFN-co (<10 U/ml antiviral activity) produced by infected cells. However, poly(I).poly(C) also induces 2,5' oligoadenylate synthetase in several different cells independently of IFN-ci This induced enzyme binds to dsRNA and catalyzes the conversion of ATP to 2,5' oligoadenylate, the activator of 2,5' oligoadenylate-dependent RNase L. The RNase, in turn, cleaves and inactivates singlestranded viral RNAs. Treatment of uninfected and HIV infected monorytes with poly(I) .poly(C) induced a potent and indistinguishable transcriptional amplification of 2,5' oligoadenylate synthetase as detected by dot blot analysis of mRNA for this enzyme (Fig. 6) . Thus, in the face ofa stringent, HIV-associated, transcriptional block in the expression ofIFN-at in the infected monocyte, poly(I)-poly(C) increased 2,5' oligoadenylate synthetase mRNA and elicited an effective antiviral reaction .
Discussion
The role ofIFN in HIV disease is both complex and seemingly paradoxical. In vitro, IFN-cx, IFN-/3, and IFN-y each have potent antiretroviral activity (16) . While IFN-ci does not prevent infection of HIV in CD4+ T cells, this cytokine significantly restricts virus replication in infected cells (20, 21, 25) . The mechanism for this antiviral effect is through induction of a partial and reversible block in the assembly and/or release of progeny virions (19, 25) . In macrophages, the antiviral action of IFN-ci is more effective than that in T cells and operates through different mechanisms. Monocytes treated with IFN-ci at the time of virus challenge show no evidence ofHIV infection . IFN-ci interrupts one or more early events in the virus replication cycle before formation of proviral DNA . Monocyte cultures infected with HIV before IFN-ot treatment show a gradual decrease in levels of p24 Ag and RT activity to baseline. HIV-induced cytopathic changes are markedly reduced, as is HIV-specific mRNA, and the frequency of productively infected cells is <1%. Virus particles released 24 h after IFN-at treatment are 1,000-fold less infectious than equal numbers of control virions . But, levels ofproviral DNA in the IFN-a-treated and control HIV infected cells are indistinguishable. Large quantities of proviral DNA in cells with little or no evidence for active transcription documents a situation approaching true microbiological latency (25) .
In HIV-infected patients, administration of IFN-ci alone for 12 wk to asymptomatic subjects decreases ability to isolate virus from blood leukocytes and reduces p24 antigenemia. In follow-up studies, none of the IFN-ot-treated patients developed AIDS-associated opportunistic infection compared with 30% of the placebo-treated group (17) .
In contrast to these promising therapeutic interventions with exogenous IFN-a, the appearance of endogenous IFN in blood during the natural history ofHIV disease is perhaps more ominous . Even though there is no evidence for direct induction of IFN by HIV itself, serum of patients with late stage HIV disease has high levels of an acid-labile IFN-Cl, a poor prognostic index that predicts onset of opportunistic infection (37, 38) . The cell source for this acid-labile IFN-a is not known. Indeed, production of all IFN types during HIV infection is suppressed. Production of IFN-y by PBMC of HIVinfected patients is significantly reduced (39) . Transcription of the IFN-,y gene, but not the ILr2 gene, is impaired in HIV-infected T cells (40) . Similarly, monocytes and PBMC from HIV-infected patients show a markedly reduced ability to secrete IFN-ci or express IFN-a mRNA after exposure to vesicular stomatitis virus, influenza A virus, or HSV type 1 infected fibroblasts (41) (42) (43) . What is most remarkable about these latter observations, is that they occur coincident with a frequency of HIV-infected cells in patient blood that is exceedingly low. About 1% of blood leukocytes harbor HIV DNA (44) (45) (46) . Of the total number of infected cells, <0.01% show active expression of HIV genes (47) . Yet production of IFN-ot in PBMC ofHIV-infected patients, cells that are at least 99% virus-free, is 1,000-fold less than that in PBMC of controls (43) .
We document in this report a profound and highly selective defect in the expression of IFN-ci genes by HIV-infected monorytes that was evident under a wide range of experimental conditions and inducing agents. The expression of other cytokine genes (TNF-(x, ILr10, ILr6) was apparently not affected. Indeed, expression of other IFN genes (IFN-w, IFN-0) was also unaffected by HIV-infection . The inability of HIV-infected monocytes to express IFN-a may represent an adaptive response by this virus to ensure its survival and unimpeded replication in monocyte target cells . It is notable that at least some antiviral mechanisms normally induced by IFN-(x can be induced in the HIV-infected monocyte by poly(I) .poly(C). This synthetic double-stranded RNA induced equivalent levels of 2,5' oligoadenylate synthetase mRNA in both control and HIV-infected monocytes. More significantly, HIV-infected monocytes treated with poly(I)-poly(C) showed a dramatic decrease in both p24 Ag and RT activity levels and HIV-specific mRNA. The activation of antiviral pathways in poly(I)-poly(C)-treated, HIV-infected monocytes may be mediated by a direct effect of this synthetic doublestranded RNA or by the low levels of IFN-/3 or IFN-w produced by infected cells . Indeed, other cytokines induced by poly(I) .poly(C), such as TNF-ot, may interact with these minor species of interferons to achieve an effective antiviral reaction. Thus, even though HIV-induces a selective block in the expression of IFN-ci genes, the pathways induced by this cytokine can still be exploited for antiviral therapy. Such pathways of antiviral activity may be important not only for HIV, but also for the many other viral infections (herpes simplex, herpes zoster, cytomegalovirus) coincident with HIV disease. For example, patients infected with HIV develop persistent, localized, and slowly progressive herpes zoster infections refractory to acyclovir therapy (48) . The HIV-associated transcriptional block in IFN-ci gene expression in the macrophages of these lesions may underlie the basic pathophysiology of this disease manifestation .
The mechanism for the transcriptional block in IFN-ci gene expression in HIVinfected, M-CSF-treated, cultured monocytes is not yet known. Remarkably, HIV-infected monocyte cultures that exhibited this near absolute IFN-ci defect showed a frequency for productively infected cells of 30-60%. If the IFN-ci defect is a direct sequela of infection, then all cells must harbor the HIV provirus, which in turn is expressed in only half of the monocyyes. Alternatively, the IFN-a defect may be mediated by a soluble factor released by HIV infected cells that affects the entire cell population . This latter hypothesis is consistent with observations on PBMC ofHIV infected patients in which a cell population that is 99% virusfree shows a 1,000-fold decrease in ability to produce IFN-a (43) . The experimental system described in this report should allow molecule identification of this putative soluble factor.
The dissociation between the expression of IFN-ci and IFN-w in HIV-infected monocyyes is of special interest . The human IFN-oi gene family consists of at least 20 nonallelic members, among which are the IFN-aII genes (49, 53) . In cows, the more than 30 IFN-aII genes represent the major source of IFN-ac and encode proteins that are acid-labile (50) . In man, the IFN-aII gene subfamily has a single functional gene that encodes IFN-w, and three or four other pseudogenes (49) (50) (51) (52) (53) . Very little is known about the regulation ofhuman IFN-aII genes or its encoded protein . IFN-w is six amino acids longer at the COOH terminus than other IFN-a . Excluding these additional amino acids, IFN-w shares a 60% homology with IFN-a proteins (homologies between other IFN-ci proteins exceed 80%) and a 30% homology with IFN-(3 (51) . Certain investigators suggest ON-aII is a distinct IFN species, perhaps a vestigial link between IFN-ci and IFN-/3 (50) . Since the bovine IFN-aII proteins are acidlabile, it is tempting to speculate that IFN-w is the entity responsible for the acid-labile IFN-ci in late-stage HIV disease. That expression of all IFN-ci genes is blocked at the transcriptional level in our in vitro system, and in cells from patients infected with HIV, and expression of IFN-w in HIV infected monocyyes is intact supports this speculation. However, definite proof of IFN-w as the acid-labile IFN-ot in HIV disease, must await sequence data for the circulating activity.
Immunodeficiency Virus-infected Monocytes
